A co-clustering model involving α5β1 integrin for the biological effects of GPI-anchored human carcinoembryonic antigen (CEA)

Journal of Cellular Physiology

Volumn 211, Issue 3, 2007, Pages 791-802

  Camacho Leal, Pilar ^a   Zhai, Alexander B ^a   Stanners, Clifford P ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FIBRONECTIN; INTEGRIN LINKED KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; VERY LATE ACTIVATION ANTIGEN 5;

ARTICLE; CELL ADHESION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN IMMOBILIZATION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANOIKIS; ANTIBODIES; ANTIGENS, CD; CACO-2 CELLS; CARCINOEMBRYONIC ANTIGEN; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; CHO CELLS; CRICETINAE; CRICETULUS; GLYCOSYLPHOSPHATIDYLINOSITOLS; HUMANS; INTEGRIN ALPHA2; INTEGRIN ALPHA5BETA1; MAP KINASE SIGNALING SYSTEM; MEMBRANE MICRODOMAINS; MYOBLASTS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTOR AGGREGATION; TRANSFECTION;

EID: 34247522572     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20989     Document Type: Article

References (88)

1. Ahmed N, Oliva K, Wang Y, Quinn M, Rice G. 2003. Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR-beta1 integrin complex in colon cancer cells. Br J Cancer 89:374-384.
2. Attwell S, Roskelley C, Dedhar S. 2000. The integrin-linked kinase (ILK) suppresses anoikis. Oncogene 19:3811-3815.
3. Baron W, Decker L, Colognato H, ffrench-Constant C. 2003. Regulation of integrin growth factor interactions in oligodendrocytes by lipid raft microdomains. Curr Biol 13:151-155.
4. Bazzoni G, Hemler ME. 1998. Are changes in integrin affinity and conformation overemphasized? Trends Biochem Sci 23:30-34.
5. Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K, Stanners CP. 1989. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 57:327-334.
6. Berra E, Diaz-Meco MT, Moscat J. 1998. The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway. J Biol Chem 273:10792-10797.
7. Blystone SD, Slater SE, Williams MP, Crow MT, Brown EJ. 1999. A molecular mechanism of integrin crosstalk: Alphavbeta3 suppression of calcium/calmodulin-dependent protein kinase II regulates alpha5beta1 function. J Cell Biol 145:889-897.
8. Brown D. 1993. The tyrosine kinase connection: How GPI-anchored proteins activate T cells. Curr Opin Immunol 5:349-354.
9. Brown DA, London E. 2000. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem 275:17221-17224.
10. Campbell ID, Ginsberg MH. 2004. The talin-tail interaction places integrin activation on PERM ground. Trends Biochem Sci 29:429-435.
11. Carman CV, Springer TA. 2003. Integrin avidity regulation: Are changes in affinity and conformation underemphasized? Curr Opin Cell Biol 15:547-556.
12. Chaurasia P, Aguirre-Ghiso JA, Liang OD, Gardsvoll H, Ploug M, Ossowski L. 2006. A region in uPAR domain III controlling a functional association with alpha 5beta 1-integrin and tumor growth. J Biol Chem 281:4852-4863.
13. Chevinsky AH. 1991. CEA in tumors of other than colorectal origin. Semin Surg Oncol 7:162-166.
14. Cluzel C, Saltel F, Lussi J, Paulhe F, Imhof BA, Wehrle-Haller B. 2005. The mechanisms and dynamics of (alpha)v(beta)3 integrin clustering in living cells. J Cell Biol 171:383-392.
15. Decker L, ffrench-Constant C. 2004. Lipid rafts and integrin activation regulate oligodendrocyte survival. J Neurosci 24:3816-3825.
16. del Pozo MA, Alderson NB, Kiosses WB, Chiang H-H, Anderson RGW, Schwartz MA. 2004. Integrins regulate Rac targeting by internalization of membrane domains. Science 303:839-842.
17. Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S. 1998. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci USA 95:11211-11216.
18. Diaz-Gonzalez F, Forsyth J, Steiner B, Ginsberg MH. 1996. Trans-dominant inhibition of integrin function. Mol Biol Cell 7:1939-1951.
19. Duxbury MS, Ito H, Ashley SW, Whang EE. 2004a. CEACAM6 cross-linking induces caveolin-1-dependent, Src-mediated focal adhesion kinase phosphorylation in BxPC3 pancreatic adenocarcinoma cells. J Biol Chem 279:23176-23182.
20. Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. 2004b. CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells. Oncogene 23:465-473.
21. Eidelman FJ, Fuks A, DeMarte L, Taheri M, Stanners CP. 1993. Human carcinoembryonic antigen, an intercellular adhesion molecule, blocks fusion and differentiation of rat myoblasts. J Cell Biol 123:467-475.
22. Fincham VJ, Brunton VG, Frame MC. 2000. The SH3 domain directs acto-myosin-dependent targeting of v-Src to focal adhesions via phosphatidylinositol 3-kinase. Mol Cell Biol 20:6518-6536.
23. Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C. 2003. PI3K/Akt and apoptosis: Size matters. Oncogene 22:8983-8998.
24. Friedrichson T, Kurzchalia TV. 1998. Microdomains of GPI-anchored proteins in living cells revealed by crosslinking. Nature 394:802-805.
25. Giancotti FG, Ruoslahti E. 1999. Integrin signaling. Science 285:1028-1032.
26. Ginsberg MH, Partridge A, Shattil SJ. 2005. Integrin regulation. Curr Opin Cell Biol 17:509-516.
27. Grashoff C, Aszodi A, Sakai T, Hunziker EB, Fassler R. 2003. Integrin-linked kinase regulates chondrocyte shape and proliferation. EMBO Rep 4:432-438.
28. Guan KL, Figueroa C, Brtva TR, Zhu T, Taylor J, Barber TD, Vojtek AB. 2000. Negative regulation of the serine/threonine kinase B-Raf by Akt. J Biol Chem 275:27354-27359.
29. Hammarstrom S. 1999. The carcinoembryonic antigen (CEA) family: Structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol 9:67-81.
30. Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L, Coppolino MG, Radeva G, Filmus J, Bell JC, Dedhar S. 1996. Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature 379:91-96.
31. Harris TJ, Siu CH. 2002. Reciprocal raft-receptor interactions and the assembly of adhesion complexes. Bioessays 24:996-1003.
32. Hato T, Pampori N, Shattil SJ. 1998. Complementary roles for receptor clustering and conformational change in the adhesive and signaling functions of integrin alphaIIb beta3. J Cell Biol 141:1685-1695.
33. Hill MM, Feng J, Hemmings BA. 2002. Identification of a plasma membrane Raft-associated PKB Ser473 kinase activity that is distinct from ILK and PDKI. Curr Biol 12:1251-1255.
34. Hogg N, Henderson R, Leitinger B, McDowall A, Porter J, Stanley P. 2002. Mechanisms contributing to the activity of integrins on leukocytes. Immunol Rev 186:164-171.
35. Howe AK, Aplin AE, Juliano RL. 2002. Anchorage-dependent ERK signaling-mechanisms and consequences. Curr Opin Genet Dev 12:30-35.
36. Huang Y, Li J, Zhang Y, Wu C. 2000. The roles of integrin-linked kinase in the regulation of myogenic differentiation. J Cell Biol 150:861-872.
37. Humphries MJ, McEwan PA, Barton SJ, Buckley PA, Bella J, Mould AP. 2003. Integrin structure: Heady advances in ligand binding, but activation still makes the knees wobble. Trends Biochem Sci 28:313-320.
38. Hynes RO. 2002. Integrins: Bidirectional, allosteric signaling machines. Cell 110:673-687. llantzis C, DeMarte L, Screaton RA, Stanners CP. 2002. Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation. Neoplasia 4:151-163.
39. Janes PW, Ley SC, Magee AI. 1999. Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor. J Cell Biol 147:447-461.
40. King WG, Mattaliano MD, Chan TO, Tsichlis PN, Brugge JS. 1997. Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation. Mol Cell Biol 17:4406-4418.
41. Kramer EM, Klein C, Koch T, Boytinck M, Trotter J. 1999. Compartmentation of Fyn kinase with glycosylphosphatidylinositol-anchored molecules in oligodendrocytes facilitates kinase activation during myelination. J Biol Chem 274:29042-29049.
42. Kunkel GR, Pederson T. 1989. Transcription of a human U6 small nuclear RNA gene in vivo withstands deletion of intragenic sequences but not of an upstream TATATA box. Nucleic Acids Res 17:7371-7379.
43. Leitinger B, Hogg N. 2002. The involvement of lipid rafts in the regulation of integrin function. J Cell Sci 115:963-972.
44. Levinthal DJ, DeFranco DB. 2004. Transient phosphatidylinositol 3-kinase inhibition protects immature primary cortical neurons from oxidative toxicity via suppression of extracellular signal-regulated kinase activation. J Biol Chem 279:11206-11213.
45. Lukashev ME, Sheppard D, Pytela R. 1994. Disruption of integrin function and induction of tyrosine phosphorylation by the autonomously expressed beta I integrin cytoplasmic domain. J Biol Chem 269:18311-18314.
46. Ly DP, Zazzali KM, Corbett SA. 2003. De novo expression of the integrin alpha5beta1 regulates alphavbeta3-mediated adhesion and migration on fibrinogen. J Biol Chem 278:21878-21885.
47. Lynch DK, Ellis CA, Edwards PA, Hiles ID. 1999. Integrin-linked kinase regulates phosphorylation of serine 473 of protein kinase B by an indirect mechanism. Oncogene 18:8024-8032.
48. McManus EJ, Collins BJ, Ashby PR, Prescott AR, Murray-Tait V, Armit LJ, Arthur JS, Alessi DR. 2004. The in vivo role of PtdIns(3,4,5)P(3) binding to PDK1 PH domain defined by knockin mutation. EMBO J 23:2071-2082.
49. Moelling K, Schad K, Bosse M, Zimmermann S, Schweneker M. 2002. Regulation of Raf-Akt Cross-talk. J Biol Chem 277:31099-31106.
50. Myslinski E, Ame JC, Krol A, Carbon P. 2001. An unusually compact external promoter for RNA polymerase III transcription of the human HIRNA gene. Nucleic Acids Res 29:2502-2509.
51. Oikawa S, Inuzuka C, Kuroki M, Matsuoka Y, Kosaki G, Nakazato H. 1989. Cell adhesion activity of non-specific cross-reacting antigen (NCA) and carcinoembryonic antigen (CEA) expressed on CHO cell surface: Homophilic and heterophilic adhesion. Biochem Biophys Res Commun 164:39-45.
52. Oikawa S, Inuzuka C, Kuroki M, Arakawa F, Matsuoka Y, Kosaki G, Nakazato H. 1991. A specific heterotypic cell adhesion activity between members of carcinoembryonic antigen family, W272 and NCA, is mediated by N-domains. J Biol Chem 266:7995-8001.
53. Ordonez C, Screaton RA, Ilantzis C, Stanners CP. 2000. Human carcinoembryonic antigen functions as a general inhibitor of anoikis. Cancer Res 60:3419-3424.
54. Ordonez C, Zhai A, Camacho-Leal MP, Fan M, Stanners CP. 2007. GPI-anchored CEA family glycoproteins CEA and CEACAM6 mediate their biological effects through activation of integrin α5β1. J Cell Physiol 210:757-765.
55. Ossowski L, Aguirre-Ghiso JA. 2000. Urokinase receptor and integrin partnership: Coordination of signaling for cell adhesion, migration and growth. Curr Opin Cell Biol 12:613-620.
56. Peck D, Walsh FS. 1993. Differential effects of over-expressed neural cell adhesion molecule isoforms on myoblast fusion. J Cell Biol 123:1587-1595.
57. Peng XD, Xu PZ, Chen ML, Hahn-Windgassen A, Skeen J, Jacobs J, Sundararajan D, Chen WS, Crawford SE, Coleman KG, Hay N. 2003. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenests in mice lacking Akt1 and Akt2. Genes Dev 17:1352-1365.
58. Persad S, Attwell S, Gray V, Mawji N, Deng JT, Leung D, Yan J, Sanghera J, Walsh MP. Dedhar S. 2001. Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: Critical roles for kinase activity and amino acids arginine 211 and serine 343. J Biol Chem 276:27462-27469.
59. Pollard JW, Stanners CP. 1979. Characterization of cell lines showing growth control isolated from both the wild type and a leucyl-tRNA synthetase mutant of Chinese hamster ovary cells. J Cell Physiol 98:571-585.
60. Qin J, Vinogradova O, Plow EF. 2004. Integrin bidirectional signaling: A molecular view. PLoS Biol 2:e169.
61. Rodgers W, Crise B, Rose JK. 1994. Signals determining protein tyrosine kinase and glycosylphosphatidylinositol-anchored protein targeting to a glycolipid-enriched membrane fraction. Mol Cell Biol 14:5384-5391.
62. Rommel C, Clarke BA, Zimmermann S, Nunez L, Rossman R, Reid K, Moelling K, Yancopoulos GD, Glass DJ. 1999. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286:1738-1741.
63. Sastry SK, Lakonishok M, Wu S, Truong TQ, Huttenlocher A, Turner CE, Horwitz AF. 1999. Quantitative changes in integrin and focal adhesion signaling regulate myoblast cell cycle withdrawal. J Cell Biol 144:1295-1309.
64. Sayama K, Yamasaki K, Hanakawa Y, Shirakata Y, Tokumaru S, Ijuin T, Takenawa T, Hashimoto K. 2002. Phosphatidylinositol 3-kinase is a key regulator of early phase differentiation in keratinocytes. J Biol Chem 277:40390-40396.
65. Screaton RA, Penn LZ, Stanners CP. 1997. Carcinoembryonic antigen, a human tumor marker, cooperates with Myc and Bcl-2 in cellular transformation. J Cell Biol 137:939-952.
66. Screaton RA, DeMarte L, Draber P, Stanners CP. 2000. The specificity for the differentiation blocking activity of carcinoembryonic antigen resides in its glycophosphatidyl-inositol anchor. J Cell Biol 150:613-626.
67. Sharma P, Varma R, Sarasij RC, Gousset K, Krishnamoorthy G, Rao M, Mayor S. 2004. Nanoscale organization of multiple GPI-anchored proteins in living cell membranes. Cell 116:577-589.
68. Shimaoka M, Takagi J, Springer TA. 2002. Conformational regulation of integrin structure and function. Annu Rev Biophys Biomol Struct 31:485-516.
69. Simons K, Ikonen E. 1997. Functional rafts in cell membranes. Nature 387:569-572.
70. Soeth E, Wirth T, List HJ, Kumbhani S, Petersen A, Neumaier M, Czubayko F, Juhl H. 2001. Controlled ribozyme targeting demonstrates an antiapoptotic effect of carcinoembryonic antigen in HT29 colon cancer cells. Clin Cancer Res 7:2022-2030.
71. Stanners CP, Fuks A. 1998. Properties of adhesion mediated by the human cea family. In: Stanners CP, editor. Cell adhesion and communication mediated by the CEA family: Basic and clinical perspectives. Amsterdam: Harwood Academic Publishers, pp 57-71.
72. Stefanova I, Horejsi V, Ansotegui IJ, Knapp W, Stockinger H. 1991. GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 254:1016-1019.
73. Stuermer CA, Lang DM, Kirsch F, Wiechers M, Deininger SO, Plattner H. 2001. Glycosylphosphatidyl inositol-anchored proteins and fyn kinase assemble in noncaveolar plasma membrane microdomains defined by reggie-1 and-2. Mol Biol Cell 12:3031-3045.
74. Suzuki T, Kiyokawa N, Taguchi T, Sekino T, Katagiri YU, Fujimoto J. 2001. CD24 induces apoptosis in human B cells via the glycolipid-enriched membrane domains/rafts-mediated signaling system. J Immunol 166:5567-5577.
75. Taheri M, Saragovi U, Fuks A, Makkerh J, Mort J, Stanners CP. 2000. Self recognition in the Ig super-family. Identification of precise subdomains in carcinoembryonic antigen required for intercellular adhesion. J Biol Chem 275:26935-26943.
76. Taheri M, Saragovi HU, Stanners CP. 2003. The adhesion and differentiation-inhibitory activities of the immunoglobulin superfamily member, carcinoembryonic antigen, can be independently blocked. J Biol Chem 278:14632-14639.
77. Tan C, Cruet-Hennequart S, Troussard A, Fazli L, Costello P, Sutton K, Wheeler J, Gleave M, Sanghera J, Dedhar S. 2004. Regulation of tumor angiogenesis by integrin-linked kinase (ILK). Cancer Cell 5:79-90.
78. Tarui T, Akakura N, Majumdar M, Andronicos N, Takagi J, Mazar AP, Bdeir K, Kuo A, Yarovoi SV, Cines DB, Takada Y. 2006. Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alphavbeta3 induces signal transduction and enhances plasminogen activation. Thromb Haemost 95:524-534.
79. Troussard AA, Mawji NM, Ong C, Mui A, St-Arnaud R, Dedhar S. 2003. Conditional knockout of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation. J Biol Chem 278:22374-22378.
80. van Kooyk Y, Figdor CG. 2000. Avidity regulation of integrins: The driving force in leukocyte adhesion. Curr Opin Cell Biol 12:542-547.
81. Vanhaesebroeck B, Alessi DR. 2000. The PI3K-PDKI connection: More than just a road to PKB. Biochem J 346:561-576.
82. Varma R, Mayor S. 1998. GPI-anchored proteins are organized in submicron domains at the cell surface. Nature 394:798-801.
83. 2+-dependent localization of integrin-linked kinase to cell junctions in differentiating keratinocytes. J Biol Chem 278:11528-11535.
84. Weitzman JB, Pujades C, Hemler ME. 1997. Integrin alpha chain cytoplasmic tails regulate "antibody-redirected" cell adhesion, independently of ligand binding. Eur J Immunol 27:78-84.
85. Wu C, Keightley SY, Leung-Hagesteijn C, Radeva G, Coppolino M, Goicoechea S, McDonald JA, Dedhar S. 1998. Integrin-linked protein kinase regulates fibronectin matrix assembly, E-cadherin expression, and tumorigenicity. J Biol Chem 273:528-536.
86. Yaffe D. 1968. Retention of differentiation potentialities during prolonged cultivation of myogenic cells. Proc Natl Acad Sci USA 61:477-483.
87. Zervas CG, Gregory SL, Brown NH. 2001. Drosophila integrin-linked kinase is required at sites of integrin adhesion to link the cytoskeleton to the plasma membrane. J Cell Biol 152:1007-1018.
88. Zhou H, Fuks A, Alcaraz G, Bolling TJ, Stanners CP. 1993. Hemophilic adhesion between Ig superfamily carcinoembryonic antigen molecules involves double reciprocal bonds. J Cell Biol 122:951-960.